Literature DB >> 22158573

Prevalence of cancer screening in older, racially diverse adults: still screening after all these years.

Keith M Bellizzi1, Erica S Breslau, Allison Burness, William Waldron.   

Abstract

BACKGROUND: While a great deal is known about cancer screening behaviors and trends in young and middle-aged adults, little is known about screening behaviors in older adults from different racial backgrounds. Our goal was to establish prevalence estimates and correlates of cancer screening, including physician recommendation in older (≥75 years), racially diverse adults.
METHODS: Data were analyzed from the National Health Interview Survey--an annual, in-person, nationwide survey used to track health trends in US civilians. The analytic sample included 49,575 individuals, of whom 1697 were 75 to 79 years old and 2376 were 80 years or older. Screening behaviors were examined according to the US Preventive Services Task Force recommendations for breast, cervical, colorectal, and prostate cancer screening.
RESULTS: Among adults aged 75 to 79 years, the percentage screened for cancer was as follows: colorectal, 57%; breast, 62%; cervical, 53%; and prostate, 56%. Among those 80 years or older, rates of screening ranged from a low of 38% for cervical cancer to a high of 50% for breast cancer. Although unadjusted screening prevalence rates differed by race/ethnicity, these differences were accounted for by low education attainment in the multivariate logistic regression model. Physician recommendation for a specific test was the largest predictor of screening. Over 50% of men and women older than 75 years report that their physicians continue to recommend screening.
CONCLUSION: A high percentage of older adults continue to be screened in the face of ambiguity of recommendations for this group.

Entities:  

Mesh:

Year:  2011        PMID: 22158573     DOI: 10.1001/archinternmed.2011.570

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  27 in total

1.  Heart disease versus cancer: understanding perceptions of population prevalence and personal risk.

Authors:  Jennifer K Scheideler; Jennifer M Taber; Rebecca A Ferrer; Emily G Grenen; William M P Klein
Journal:  J Behav Med       Date:  2017-06-02

2.  The doctor is just a messenger: beliefs of ultraorthodox Jewish women in regard to breast cancer and screening.

Authors:  Anat Freund; Miri Cohen; Faisal Azaiza
Journal:  J Relig Health       Date:  2014-08

3.  Pre-screening Discussions and Prostate-Specific Antigen Testing for Prostate Cancer Screening.

Authors:  Jun Li; Guixiang Zhao; Ingrid J Hall
Journal:  Am J Prev Med       Date:  2015-05-18       Impact factor: 5.043

4.  Screening outcomes in older US women undergoing multiple mammograms in community practice: does interval, age, or comorbidity score affect tumor characteristics or false positive rates?

Authors:  Dejana Braithwaite; Weiwei Zhu; Rebecca A Hubbard; Ellen S O'Meara; Diana L Miglioretti; Berta Geller; Kim Dittus; Dan Moore; Karen J Wernli; Jeanne Mandelblatt; Karla Kerlikowske
Journal:  J Natl Cancer Inst       Date:  2013-02-05       Impact factor: 13.506

5.  A pilot study to examine colorectal cancer screening in two assisted living communities.

Authors:  Kathryn L Moore; Carmen L Lewis; Sheryl Zimmerman; Kimberly Ward; David Reed; Robert Rodriguez; Christine E Kistler
Journal:  J Am Geriatr Soc       Date:  2014-02       Impact factor: 5.562

6.  Probability of an abnormal screening prostate-specific antigen result based on age, race, and prostate-specific antigen threshold.

Authors:  Roxanne Espaldon; Katharine A Kirby; Kathy Z Fung; Richard M Hoffman; Adam A Powell; Stephen J Freedland; Louise C Walter
Journal:  Urology       Date:  2014-01-16       Impact factor: 2.649

7.  Refining physician quality indicators for screening mammography in older women: distinguishing appropriate use from overuse.

Authors:  Alai Tan; Yong-Fang Kuo; Linda S Elting; James S Goodwin
Journal:  J Am Geriatr Soc       Date:  2013-03-01       Impact factor: 5.562

8.  Effect of Patient Navigation on Breast Cancer Screening Among African American Medicare Beneficiaries: A Randomized Controlled Trial.

Authors:  Jessie Kimbrough Marshall; Olive M Mbah; Jean G Ford; Darcy Phelan-Emrick; Saifuddin Ahmed; Lee Bone; Jennifer Wenzel; Gary R Shapiro; Mollie Howerton; Lawrence Johnson; Qiana Brown; Altovise Ewing; Craig Evan Pollack
Journal:  J Gen Intern Med       Date:  2015-08-11       Impact factor: 5.128

9.  Comparing Prognostic Tools for Cancer Screening: Considerations for Clinical Practice and Performance Assessment.

Authors:  Craig Evan Pollack; Amanda L Blackford; Nancy L Schoenborn; Cynthia M Boyd; Kimberly S Peairs; Eva H DuGoff
Journal:  J Am Geriatr Soc       Date:  2016-04-30       Impact factor: 5.562

10.  Mammography use among women ages 40-49 after the 2009 U.S. Preventive Services Task Force recommendation.

Authors:  Lauren D Block; Marian P Jarlenski; Albert W Wu; Wendy L Bennett
Journal:  J Gen Intern Med       Date:  2013-05-15       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.